Isorhamnetin inhibits progression of ovarian cancer by targeting ESR1 | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Isorhamnetin inhibits progression of ovarian cancer by targeting ESR1

Authors:: Manman Wang; Zhengtan Xu; Qi Cai; Yanmei Deng; Weiqiao Shi; Hongyu Zhou; Dajiang Wang; Jian Li

Reference:: Annals of Translational Medicine; 2022; 10; 1216

DOI:: 10.21037/atm-22-5064

See Abstract

Key Words:: Network pharmacology; KEGG; isorhamnetin; ovarian cancer; target protein; ESR1; SKOV3; HO8910; mice; animal experiments

Back to index